Antitrust Antitrust

GSK's pay-for-delay judgment could mark 'end of an era' for antitrust enforcers, EU official says

By Michael Acton
  • 05 Mar 2020 06:41
  • 05 Mar 2020 06:41
GSK’s pay-for-delay judgment — handed down by judges at the EU’s top court earlier this year — may be the “end of an era” for the EU’s antitrust regulator, allowing it to refocus enforcement efforts elsewhere in the pharmaceutical sector, an EU competition official has said.

"For the past decade we have been essentially investigating

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News